Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Monday, June 12, 2017

The People behind the P&G TMA reducing supplement

Readers have been aware since 2015 that a trimethylamine reducing therapy has been on the cards. Here is some background (and guesswork) to the 'therapy' (speculated to be a supplement).

The 2 organisations involved  :
Cleveland Clinic (Innovations)
Procter & Gamble

Cleveland Clinic :
Has a long history of being a pioneer in heart disease research and treatment.

Dr Stanley Hazen (lab) :
Dr Stanley Hazen is one of the world's leading Heart Disease doctor's and researcher.

In 2011 his lab (Hazen et al) put forward a paper saying that Trimethylamine-n-oxide (TMAO) may be a strong causal factor for developing Heart Disease.pubmed ).
One obvious potential therapy was to stop gut microbes altering the likes of choline into TMA. One possible way to do this would be to interfere with the choline-TMA metabolism.
This seems to be what the patented product will do.
The lab has released many TMAO-CVD papers since 2011.
It seems most of the papers are have Dr Tang as lead researcher.
In this case the end product will probably come under the Cleveland Clinic INNOVATIONS dept. Or Cleveland Heartlab.

Procter & Gamble :
P&G is one of the biggest manufacturer and brand for household products, including some nutrition products.

It seems Cleveland ( Innovations ) have teamed up with P&G probably mostly under a licence agreement whereby P&G are the sellers of the product.

P&G Nutrition products :
A guess is that the TMA-inhibiting product will be sold as part of the P&G Nutrition range.
Perhaps as part of the 'Meta' range.
P&G Nutrition online shop
P&G current heart health product

Product patent (current version Dec 2016) : link

Inventor names on the patent :
Garcia-garcia, Jose Carlos (Cincinnati, OH, US)
Hazen, Stanley Leon (Pepper Pike, OH, US)
Wos, John August (Mason, OH, US)

Garcia-garcia, Jose Carlos.
Principal Scientist at Procter & Gamble

Hazen, Stanley Leon

Wos, John August
Principal Scientist at Procter & Gamble

When will we hear the latest news ?
Probably in a press release. Until they are ready, they will keep all info secret.
One idea is to follow Cleveland Innovations on Twitter.
But it will likely be major news when it is available.

Aug 2015 Press Release

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Post a Comment